Department of Biomorphological and Functional Sciences, Institute of Biostructures and Bioimages of the National Research Council, University of Naples Federico II and SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy.
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):163-7. doi: 10.1007/s00259-009-1250-6.
Multimodality imaging represents an area of rapid growth with important professional implication for both nuclear medicine physicians and radiologists throughout Europe. As a preliminary step for future action aimed at improving the quality and accessibility of PET/SPECT/CT multimodality imaging practice in Europe, the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) performed a survey among the individual membership of both societies to obtain information on the status of multimodality imaging in their facilities and their future visions on training for combined modalities.
A questionnaire was forwarded to all individual members of the EANM and ESR. The main subject matter of the questionnaire related to: (1) study performance,current procedures, current equipment including its supervisory personnel at respondents' individual facilities and (2)vision of future practice, performance and the potential for combined interdisciplinary viewing and training for future professionals.
The reporting and the billing procedures of multimodality imaging studies are very heterogeneous in European countries. The majority of the members of both societies believe that the proportion of PET/CT conducted as a full diagnostic CT with contrast enhancement will increase over time. As expected, (18)F-FDG is the most commonly used PET tracer for clinical applications. The large majority of respondents were in favour of an interdisciplinary training programme being developed on a European level together by the EANM and the ESR and the respective sections of the European Union of Medical Specialists.
The results of this survey show that there is wide heterogeneity in the current practice of multimodality imaging in Europe. This situation may limit the full potential and integration of multimodality imaging within the clinical arena. There is a strong desire within both specialties for the development of interdisciplinary training to address some of these issues.
多模态成像代表了一个快速发展的领域，对整个欧洲的核医学医师和放射科医师都有重要的专业意义。作为未来旨在提高欧洲 PET/SPECT/CT 多模态成像实践质量和可及性的行动的初步步骤，欧洲核医学协会（EANM）和欧洲放射学会（ESR）对两个学会的个人会员进行了调查，以获取有关其设施中多模态成像的现状及其对联合方式培训的未来愿景的信息。
向 EANM 和 ESR 的所有个人会员发送了一份问卷。问卷的主要主题涉及：（1）研究表现、当前程序、当前设备，包括受访者个人设施中的监督人员，以及（2）未来实践、表现的愿景以及未来专业人员联合跨学科观察和培训的潜力。
欧洲国家的多模态成像研究的报告和计费程序非常多样化。两个学会的大多数成员都认为，随着时间的推移，作为带有对比增强的全诊断 CT 进行的 PET/CT 的比例将会增加。不出所料，（18）F-FDG 是最常用于临床应用的 PET 示踪剂。绝大多数受访者赞成由 EANM 和 ESR 以及欧洲联盟医学专家各自的部门共同在欧洲一级制定一个跨学科培训计划。
这项调查的结果表明，欧洲多模态成像的当前实践存在广泛的异质性。这种情况可能限制了多模态成像在临床领域的充分潜力和整合。这两个专业领域都强烈希望开展跨学科培训，以解决其中的一些问题。
